Change in the composition of the OECI Accreditation & Designation Board


February 12, 2016 
 
On behalf of the Accreditation and Designation (A&D) Group we announce the new chair of the A&D working group: Simon Oberst.

Simon Oberst is currently Director of Clinical Development at the Cambridge Cancer Centre. Simon served actively as member of the A&D Board and chaired several audit groups.

After thirteen years of designing and launching the A&D programme, Mahasti Saghatchian, transfers her activities as a chair and will stay as a board member of the OECI A&D group. We express our gratitude for her dedication to the A&D programme. In the last thirteen years the A&D programme has included successfully more than 30 centres so far.

Besides Simon Oberst we also welcome Peter Nagy, director of International relations and head of molecular immunology and toxicity department (National Institute of Oncology, Budapest Hungary), as a new A&D Board member.


Since 2016, the composition of the A&D Board is:
Simon Oberst (chair), Director of Clinical Development, Cambridge Cancer Centre, Cambridge, UK
Mahasti Saghatchian, Medical Oncologist, Institute Gustave Roussy, Villejuif, France
Wim van Harten, Director Organisation and Managment,Netherlands Cancer Institute, Amsterdam, The Netherlands
Paolo di Paoli, Scientific Director, Centro di Riferimento Oncologico - Istituto Nazionale Tumori, Aviano, Italy
Peter Nagy, director of International relations and head of molecular immunology and toxicity department, National Institute of Oncology, Budapest Hungary